Investors put skin in Peninsula biotech's psoriasis game, and it delivers results

Alumis is now armed with a half-billion in cash and a wide range of targets, starting with psoriasis.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 12, 2024 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news